Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- University of Oslo
- Harvard University
- University of British Columbia
- Ellison Institute of Technology
- Missouri University of Science and Technology
- Zintellect
- City of Hope
- Dana-Farber Cancer Institute (DFCI)
- University of Birmingham
- Nanyang Technological University
- National University of Singapore
- King's College London
- National Center for Toxicological Research (NCTR)
- Northeastern University
- Center for Biologics Evaluation and Research (CBER)
- Center for Drug Evaluation and Research (CDER)
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Max Planck Institute of Biochemistry, Martinsried
- NTNU - Norwegian University of Science and Technology
- UNIVERSITY OF SOUTHAMPTON
- University of Leeds
- Università degli Studi di Padova
- Aarhus University
- Amgen
- CCMAR – Centro de Ciências do Mar do Algarve
- CIC bioGUNE
- CUNY Graduate Center
- Central Michigan University
- Centre d'innovation biomédicale - Université de Montréal
- Cold Spring Harbor Laboratory
- Cori Institute of Molecular and Computational Metabolism
- European Molecular Biology Laboratories
- Francis Crick Institute
- Humboldt-Universität zu Berlin
- Indiana University
- Naturalis
- Oden Institute for Computational Engineering and Sciences
- Princeton University
- Research Center for Molecular Medicine (CeMM), ÖAW
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- SUNY University at Buffalo
- Simons Foundation/Flatiron Institute
- Tampere University
- UiT The Arctic University of Norway
- University of Bergen
- University of California
- University of Colorado
- University of Kansas Medical Center
- University of London
- University of Minnesota
- University of Sydney
- University of Texas at Austin
- Université de Strasbourg
- eQuest
- Łukasiewicz PORT
- 45 more »
- « less
-
Field
-
. Norbert Perrimon’s group in the Program of Genetics at Harvard Medical School. Perrimon lab is actively generating data sets of omics scale and this position will involve working with other post-doc
-
Grade 7 (£41,064 – £48,222 p.a. depending on experience) We are open to discussing flexible working arrangements. Are you an ambitious researcher looking for your next challenge with a computational
-
working at the intersection of uterine health, gynecologic oncology, computational biology, clinical informatics, and artificial intelligence. The lab develops and applies innovative data science and AI
-
potential progression once in post to £48,822 Grade: 7 Full Time, Fixed Term contract up to June 2028 Closing date: 17th September 2026 Background This role is part of the philanthropically funded programme
-
, computational biology and AI, microbial, plant and human cell biology, genomics, robotics and automation, and nucleic acids chemistry.). Track record of delivering ambitious research projects to a high standard
-
Knowledge, Skills and Experience: Completed a PhD in a relevant field (e.g., synthetic biology, computational biology and AI, microbial, plant and human cell biology, genomics, robotics and automation, and
-
tasks and duties commensurate with the role. Requirements Essential and Desirable Knowledge, Skills and Experience: Completed a PhD in a relevant field (e.g., synthetic biology, computational biology and
-
: 30th September 2026 Background To create and contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research
-
, researchers, educators and innovators to tackle humanity’s greatest challenges in four transformative areas: Health, Medical Science & Generative Biology Food Security & Sustainable Agriculture Climate Change
-
is designed to identify novel therapeutics for substance use disorders. We will apply novel network biology approaches, pathway modeling, and simulation computational tools to prioritize potential